CCRM and Cytiva, formerly part of GE Healthcare Life Sciences, have renewed their collaboration agreement for continued operation of the Centre for Advanced Therapeutic Cell Technologies (CATCT), which was created to accelerate the development and adoption of cell manufacturing technologies for novel regenerative medicine-based therapies.   With Health Canada and the U.S. Food and Drug Administration (FDA) beginning to approve and reimburse cell and gene therapies in significant numbers, the dem...